Total Payments
$2,789
2024 Payments
$637.25
Companies
26
Transactions
94
Medicare Patients
12,576
Medicare Billing
$968,556
Payment Breakdown by Category
Food & Beverage$2,178 (78.1%)
Travel$412.60 (14.8%)
Education$198.95 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,178 | 91 | 78.1% |
| Travel and Lodging | $412.60 | 1 | 14.8% |
| Education | $198.95 | 2 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith & Nephew, Inc. | $412.60 | 1 | $0 (2017) |
| ABBVIE INC. | $350.67 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $347.13 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $314.09 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $221.31 | 6 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $178.43 | 8 | $0 (2024) |
| Amgen Inc. | $113.65 | 5 | $0 (2024) |
| UCB, Inc. | $111.06 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $110.61 | 4 | $0 (2024) |
| PFIZER INC. | $95.13 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $637.25 | 25 | Janssen Biotech, Inc. ($153.42) |
| 2023 | $668.51 | 22 | E.R. Squibb & Sons, L.L.C. ($168.07) |
| 2022 | $180.00 | 9 | PFIZER INC. ($25.97) |
| 2021 | $198.58 | 9 | GENZYME CORPORATION ($44.12) |
| 2020 | $95.76 | 4 | Novartis Pharmaceuticals Corporation ($38.65) |
| 2019 | $198.39 | 10 | Novartis Pharmaceuticals Corporation ($55.38) |
| 2018 | $156.52 | 5 | Celgene Corporation ($88.75) |
| 2017 | $654.07 | 10 | Smith & Nephew, Inc. ($412.60) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Immunology | ||||||
| 09/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.79 | General |
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.68 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $31.07 | General |
| 06/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Dermatology | ||||||
| 04/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Immunology | ||||||
| 03/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Dermatology | ||||||
| 02/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Oncology | ||||||
| 02/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Immunology | ||||||
| 02/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Dermatology | ||||||
| 01/23/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: ACNE | ||||||
| 01/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,521 | 6,614 | $788,056 | $268,702 |
| 2022 | 19 | 3,316 | 6,328 | $746,474 | $256,579 |
| 2021 | 18 | 2,984 | 5,554 | $650,895 | $239,707 |
| 2020 | 16 | 2,755 | 5,382 | $446,338 | $203,568 |
Total Patients
12,576
Total Services
23,878
Medicare Billing
$968,556
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 886 | 1,098 | $206,930 | $66,592 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 398 | 443 | $105,326 | $36,530 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 718 | 854 | $120,646 | $34,520 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 334 | $80,450 | $32,195 | 40.0% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 23 | 230 | $49,489 | $23,288 | 47.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 98 | 120 | $40,211 | $16,269 | 40.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 514 | 2,778 | $38,909 | $14,484 | 37.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 179 | 191 | $40,467 | $13,179 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 130 | 130 | $34,681 | $8,630 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $19,862 | $6,312 | 31.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 34 | $13,433 | $4,344 | 32.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 95 | 98 | $10,610 | $3,987 | 37.6% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 37 | 171 | $11,360 | $2,723 | 24.0% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 21 | 21 | $5,246 | $2,038 | 38.9% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 13 | $5,034 | $1,818 | 36.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 28 | 28 | $3,930 | $1,149 | 29.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 15 | $1,471 | $642.72 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 838 | 1,031 | $188,195 | $61,265 | 32.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 386 | 432 | $103,320 | $33,953 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 661 | 836 | $118,444 | $33,459 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 308 | $73,875 | $27,608 | 37.4% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 20 | 264 | $54,971 | $27,174 | 49.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 473 | 2,672 | $37,343 | $14,243 | 38.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 169 | 180 | $38,190 | $12,075 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 147 | 147 | $35,205 | $10,830 | 30.8% |
About Dr. David Jaffe, MD
Dr. David Jaffe, MD is a Dermatopathology healthcare provider based in Havre De Grace, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427023811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jaffe, MD has received a total of $2,789 in payments from pharmaceutical and medical device companies, with $637.25 received in 2024. These payments were reported across 94 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,178).
As a Medicare-enrolled provider, Jaffe has provided services to 12,576 Medicare beneficiaries, totaling 23,878 services with total Medicare billing of $968,556. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Clinical & Laboratory Dermatological Immunology, Pediatric Dermatology
- Location Havre De Grace, MD
- Active Since 02/21/2006
- Last Updated 02/16/2023
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427023811
Products in Payments
- Taylor Spatial Frame (Device) $412.60
- TREMFYA (Drug) $269.73
- Sotyktu (Drug) $221.31
- Otezla (Drug) $183.76
- Humira (Biological) $171.23
- COSENTYX (Biological) $155.51
- DUPIXENT (Biological) $154.73
- COSENTYX (Drug) $121.98
- BLU-U (Medical Supply) $89.15
- SKYRIZI (Biological) $89.06
- Cimzia (Drug) $77.04
- EUCRISA (Drug) $70.13
- Odomzo (Drug) $67.83
- DUPIXENT (Drug) $65.95
- VTAMA (Drug) $52.46
- RINVOQ (Biological) $46.49
- Tremfya (Drug) $44.36
- OPZELURA (Drug) $43.55
- AMZEEQ (Drug) $35.96
- Bimzelx (Biological) $34.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.